Oak Hill Bio Overview
- Status
-
Private
- Employees
-
29
- Latest Deal Type
-
PIPE
- (Announced)
- Latest Deal Amount
-
$100M
- Investors
-
4
Oak Hill Bio General Information
Description
Oak Hill Bio Inc is a clinical-stage biotechnology company focused on acquiring and developing therapeutics for rare diseases with unmet medical needs. Its flagship program, rugonersen (OHB-724), is an antisense oligonucleotide in Phase 3 clinical development for the treatment of Angelman syndrome.
Contact Information
Website
www.oakhillbio.comCorporate Office
- 3rd Floor 1 Ashley Road
- Cheshire
- Altrincham WA14 2DT
- England, United Kingdom
Corporate Office
- 3rd Floor 1 Ashley Road
- Cheshire
- Altrincham WA14 2DT
- England, United Kingdom
Oak Hill Bio Timeline
Oak Hill Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. PIPE | 27-Jun-2026 | $100M | Announced | Clinical Trials - Phase 3 | ||
| 4. Reverse Merger | 27-Jul-2026 | Announced | Clinical Trials - Phase 3 | |||
| 3. Early Stage VC (Series A) | 01-Jun-2026 | Completed | Clinical Trials - Phase 3 | |||
| 2. Seed Round | 16-Nov-2025 | $6.45M | $6.45M | Completed | Clinical Trials - Phase 2 | |
| 1. Debt - General | 28-Jan-2022 | Completed | Clinical Trials - Phase 2 |
Oak Hill Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Series B Preferred |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Oak Hill Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Oak Hill Bio Patents
Oak Hill Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202418971-D0 | Method | Pending | 23-Dec-2024 | ||
| GB-202418976-D0 | Method | Inactive | 23-Dec-2024 | ||
| GB-202418979-D0 | Method | Inactive | 23-Dec-2024 | ||
| GB-202319443-D0 | Treatment | Inactive | 18-Dec-2023 | ||
| GB-202315046-D0 | Method | Inactive | 29-Sep-2023 |
Oak Hill Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Oak Hill Bio Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Balyasny Asset Management | Hedge Fund | Minority | ||
| Janus Henderson Investors | Asset Manager | Minority | ||
| KCap Biotechnology | Hedge Fund | Minority | ||
| venBio | Venture Capital | Minority |
Oak Hill Bio Investments & Acquisitions (2)
Oak Hill Bio’s most recent deal was a Merger/Acquisition with Research Alliance III for . The deal was made on 27-Jul-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Research Alliance III | 27-Jul-2026 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) | ||
| Roche (Global Rights of Rugonersen) | 15-Apr-2025 | Corporate Asset Purchase | Buildings and Property |
Oak Hill Bio FAQs
-
Where is Oak Hill Bio headquartered?
Oak Hill Bio is headquartered in Altrincham, United Kingdom.
-
What is the size of Oak Hill Bio?
Oak Hill Bio has 29 total employees.
-
What industry is Oak Hill Bio in?
Oak Hill Bio’s primary industry is Drug Discovery.
-
Is Oak Hill Bio a private or public company?
Oak Hill Bio is a Private company.
-
What is Oak Hill Bio’s current revenue?
The current revenue for Oak Hill Bio is .
-
How much funding has Oak Hill Bio raised over time?
Oak Hill Bio has raised $38.9M.
-
Who are Oak Hill Bio’s investors?
Balyasny Asset Management, Janus Henderson Investors, KCap Biotechnology, and venBio have invested in Oak Hill Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
